Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation
Year: 2024
Type: article
Study design: Observational Study
Abstract: This retrospective case series compares vitiligo resulting from immune checkpoint inhibitor (ICI) therapy vs preexisting vitiligo among patients receiving ICI treatment for cancer.
Source: JAMA Dermatology
Authors: Michela Starace, Stephano Cedirian, Luca Rapparini, Alessandro Pileri, Cristina Carrera, Priscila Giavedoni, M. Teresa Alonso de Leon, Lukas Kraehenbuehl, Yannick S. Elshot, Zoe Apalla, Chryssoula Papegeorgiou, Vasiliki Nikolaou, Tatjana Radevic, Zsuzsanna Lengyel, Pietro Sollena, Ketty Peris, Ernesto Rossi, Davide Fattore, Dimitra Koumaki, Aram Boada, Ana-Maria Forsea, Sonia Segura, Azael Freites-Martinez, Julia Riganti, Emily Avitan-Hersh, Nada Saffuri, Lucie Peuvrel, Frédéric Dezoteux, Bianca Maria Piraccini, Vincent Sibaud
Institutions: IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, Instituto de Salud Carlos III, Centre for Biomedical Network Research on Rare Diseases, Hospital Clínic de Barcelona, Universitat de Barcelona, University of Zurich, University Hospital Zurich, The Netherlands Cancer Institute, Amsterdam University Medical Centers, University of Amsterdam, Aristotle University of Thessaloniki, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Military Medical Academy, University of Defence, University of Pecs, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, University of Naples Federico II, University Hospital of Heraklion, Carol Davila University of Medicine and Pharmacy, Hospital Del Mar, Parc de Salut, Hospital del Mar Research Institute, Universidad Europea de Madrid, Hospital Italiano de Buenos Aires, Technion – Israel Institute of Technology, Rambam Health Care Campus, Institut de Cancérologie de l'Ouest, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Lille Inflammation Research International Center, Institute for Translational Research in Inflammation, Institut universitaire du cancer de Toulouse Oncopole
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4405721520